Researchers Joshua Smith and Stacey Gifford from IBM's Nanobiotechnology Program cover the latest research on the relevant biology found in fluids from liquid biopsies and discuss opportunities in microfluidics for disruptive technology development to isolate and interrogate these biomarkers, aiding disease diagnosis, prognosis, and treatment-response monitoring.
- Webinar
- Micro and Nanotechnologies
